Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-10-29

Clinical Trial Update: The Perinatal Synergistic Multi-component Intervention to alLeviate dEpressive Symptoms. A Case Series [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating a perinatal multi-component intervention for postpartum depression has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Washington University School of Medicine | Conditions: Postpartum Depression | Phase 2, Phase 3 | Status: WITHDRAWN